Shopping Cart
- Remove All
- Your shopping cart is currently empty
Fontolizumab (HuZAF) is a humanised IgG1 monoclonal anti-IFN-gamma (IFN-γ) antibody with good tolerability and low immunogenicity. It is administered intravenously in clinical settings and can be used for the study of Crohn's disease.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $332 | In Stock | |
5 mg | $996 | In Stock | |
10 mg | $1,570 | In Stock |
Description | Fontolizumab (HuZAF) is a humanised IgG1 monoclonal anti-IFN-gamma (IFN-γ) antibody with good tolerability and low immunogenicity. It is administered intravenously in clinical settings and can be used for the study of Crohn's disease. |
Alias | HuZAF, Anti-Human IFNG Recombinant Antibody |
Molecular Weight | 150 (kDa) |
Cas No. | 326859-36-3 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.